Literature DB >> 21792942

Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy?

Fabrizio Di Benedetto, Massimiliano Berretta, Nicola De Ruvo, Giuseppe Tarantino, Giuseppe D'Amico, Roberto Ballarin, Rosa Maria Iemmolo, Giorgio E Gerunda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21792942     DOI： 10.1002/jso.22039

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  3 in total

Review 1.  Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature.

Authors:  Giuseppe Tarantino; Paolo Magistri; Roberto Ballarin; Raffaele Di Francia; Massimiliano Berretta; Fabrizio Di Benedetto
Journal:  Front Pharmacol       Date:  2016-10-21       Impact factor: 5.810

Review 2.  Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma.

Authors:  Massimiliano Berretta; Luca Rinaldi; Fabrizio Di Benedetto; Arben Lleshi; Vallì De Re; Gaetano Facchini; Paolo De Paoli; Raffaele Di Francia
Journal:  Front Pharmacol       Date:  2016-11-09       Impact factor: 5.810

Review 3.  Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.

Authors:  Massimiliano Berretta; Carla Cavaliere; Lara Alessandrini; Brigida Stanzione; Gaetano Facchini; Luca Balestreri; Tiziana Perin; Vincenzo Canzonieri
Journal:  Oncotarget       Date:  2017-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.